Development of PHY606 as Adjunct Therapy for Anemia Patients
Status:
Completed
Trial end date:
2019-11-18
Target enrollment:
Participant gender:
Summary
Many reasons can cause anemia, decreased RBC production or increased destruction of
circulation RBC. The investigators investigate the Danggui Buxue Tang (PHY606) composed of
Angelicae Sinensis Radix and Astragali Radix in the fields of genomic and metabolomics in the
healthy people and the patiens with anemia.